Ferrocene-biotin conjugates targeting cancer cells: Synthesis, interaction with avidin, cytotoxic properties and the crystal structure of the complex of avidin with a biotin-linker-ferrocene conjugate

Organometallics

Volumn 32, Issue 20, 2013, Pages 5774-5783

  Plazìuk, Damian ^a   Zakrzewski, Janusz ^a   Salmain, Michèle ^b   Błauzì, Andrzej ^a   Rychlik, Błazìej ^a   Strzelczyk, Paweł ^c   Bujacz, Anna ^c   Bujacz, Grzegorz ^c  

^a UNIVERSITY OF LODZ   (Poland)

^b PSL RESEARCH UNIVERSITY   (France)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCONJUGATES; CANCER CELL LINES; CANCER CELLS; CARBOXYLIC GROUP; DESTHIOBIOTIN; FRIEDEL-CRAFTS ACYLATION; HIGH AFFINITY; PROTEIN BINDING;

BIOCHEMISTRY; CELL CULTURE; CELLS; CYTOTOXICITY; GLYCOPROTEINS; KETONES; ORGANOMETALLICS;

COENZYMES;

EID: 84887127206     PISSN: 02767333     EISSN: 15206041     Source Type: Journal    
DOI: 10.1021/om4003126     Document Type: Article

References (65)

1. Ornelas, C. Application of ferrocene and its derivatives in cancer research New J. Chem. 2011, 35 (10) 1973
2. Fouda, M. F. R.; Abd-Elzaher, M. M.; Abdelsamaia, R. A.; Labib, A. A. On the medicinal chemistry of ferrocene Appl. Organomet. Chem. 2007, 21 (8) 613-625
3. PlazÌuk, D.; Rychlik, B.; BłauzÌ, A.; Domagała, S. Synthesis, electrochemistry and anticancer activity of novel ferrocenyl phenols prepared via azide-alkyne 1,3-cycloaddition reaction J. Organomet. Chem. 2012, 715 (0) 102-112
4. Plazuk, D.; Wieczorek, A.; Blauz, A.; Rychlik, B. Synthesis and biological activities of ferrocenyl derivatives of paclitaxel MedChemComm 2012, 3 (4) 498-501
5. Vessières, A. Metal carbonyl tracers and the ferrocifen family: Two facets of bioorganometallic chemistry J. Organomet. Chem. 2013, 734 (0) 3-16
6. Gormen, M.; Plazuk, D.; Pigeon, P.; Hillard, E. A.; Plamont, M. A.; Top, S.; Vessières, A.; Jaouen, G. Comparative toxicity of [3]ferrocenophane and ferrocene moieties on breast cancer cells Tetrahedron Lett. 2010, 51 (1) 118-120
7. Plazuk, D.; Vessières, A.; Hillard, E. A.; Buriez, O.; Labbé, E.; Pigeon, P.; Plamont, M. A.; Amatore, C.; Zakrzewski, J.; Jaouen, G. A [3]ferrocenophane polyphenol showing a remarkable antiproliferative activity on breast and prostate cancer cell lines J. Med. Chem. 2009, 52 (15) 4964-4967
8. Navarro, M.; Castro, W.; Biot, C. Bioorganometallic Compounds with Antimalarial Targets: Inhibiting Hemozoin Formation Organometallics 2012, 31 (16) 5715-5727
9. Chavain, N.; Biot, C. Organometallic complexes: new tools for chemotherapy Curr. Med. Chem. 2010, 17 (25) 2729-2745
10. Dive, D.; Biot, C. Ferrocene Conjugates of Chloroquine and other Antimalarials: the Development of Ferroquine, a New Antimalarial ChemMedChem 2008, 3 (3) 383-391
11. Dubar, F.; Khalife, J.; Brocard, J.; Dive, D.; Biot, C. Ferroquine, an Ingenious Antimalarial Drug -Thoughts on the Mechanism of Action Molecules 2008, 13 (11) 2900-2907
12. Plazuk, D.; Zakrzewski, J.; Salmain, M. Biotin as acylating agent in the Friedel-Crafts reaction. Avidin affinity of biotinyl derivatives of ferrocene, ruthenocene and pyrene and fluorescence properties of 1-biotinylpyrene Org. Biomol. Chem. 2011, 9 (2) 408-417
13. Bildstein, L.; Dubernet, C.; Couvreur, P. Prodrug-based intracellular delivery of anticancer agents Adv. Drug Delivery Rev. 2011, 63 (1-2) 3-23
14. Yang, W.; Cheng, Y.; Xu, T.; Wang, X.; Wen, L.-p. Targeting cancer cells with biotin-dendrimer conjugates Eur. J. Med. Chem. 2009, 44 (2) 862-868
15. Russell-Jones, G.; McTavish, K.; McEwan, J.; Rice, J.; Nowotnik, D. Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours J. Inorg. Biochem. 2004, 98 (10) 1625-1633
16. Ojima, I. Guided Molecular Missiles for Tumor-Targeting Chemotherapy-Case Studies Using the Second-Generation Taxoids as Warheads Acc. Chem. Res. 2007, 41 (1) 108-119
17. Chen, S.; Zhao, X.; Chen, J.; Chen, J.; Kuznetsova, L.; Wong, S. S.; Ojima, I. Mechanism-Based Tumor-Targeting Drug Delivery System. Validation of Efficient Vitamin Receptor-Mediated Endocytosis and Drug Release Bioconjugate Chem. 2010, 21 (5) 979-987
18. Hirsch, J. D.; Eslamizar, L.; Filanoski, B. J.; Malekzadeh, N.; Haugland, R. P.; Beechem, J. M.; Haugland, R. P. Easily reversible desthiobiotin binding to streptavidin, avidin, and other biotin-binding proteins: uses for protein labeling, detection, and isolation Anal. Biochem. 2002, 308 (2) 343-357
19. Muto, Y.; Murai, Y.; Sakihama, Y.; Hashidoko, Y.; Hashimoto, M. Effective Friedel-Crafts Acylation of Biotin Acid Chloride in Trifluoromethanesulfonic Acid Biosci., Biotechnol., Biochem. 2012, 76 (11) 2162-2164
20. Zempleni, J.; Wijeratne, S. S. K.; Hassan, Y. I. Biotin. BioFactors 2009, 35 (1) 36-46
21. Plazuk, D.; Zakrzewski, J. Friedel-Crafts acylation of ferrocene with alkynoic acids J. Organomet. Chem. 2009, 694 (12) 1802-1806
22. Anderson, K. W.; Tepe, J. J. The First Intermolecular Friedel-Crafts Acylation with β-Lactams Org. Lett. 2002, 4 (3) 459-461
23. Katritzky, A. R.; Jiang, R.; Suzuki, K. N-Tfa- and N-Fmoc-(α- aminoacyl)benzotriazoles as Chiral C-Acylating Reagents under Friedel-Crafts Reaction Conditions J. Org. Chem. 2005, 70 (13) 4993-5000
24. Di Gioia, M. L.; Leggio, A.; Liguori, A.; Napoli, A.; Siciliano, C.; Sindona, G. Facile Approach to Enantiomerically Pure α-Amino Ketones by Friedel-Crafts Aminoacylation and Their Conversion into Peptidyl Ketones J. Org. Chem. 2001, 66 (21) 7002-7007
25. Itoh, O.; Honnami, T.; Amano, A.; Murata, K.; Koichi, Y.; Sugita, T. Friedel-Crafts.alpha.-aminoacylation of alkylbenzene with a chiral N-carboxy-.alpha.-amino acid anhydride without loss of chirality J. Org. Chem. 1992, 57 (26) 7334-7338
26. Nordlander, J. E.; Njoroge, F. G.; Payne, M. J.; Warman, D. N-(Trifluoroacetyl)-.alpha.-amino acid chlorides as chiral reagents for Friedel-Crafts synthesis J. Org. Chem. 1985, 50 (19) 3481-3484
27. Nordlander, J. E.; Payne, M. J.; Njoroge, F. G.; Balk, M. A.; Laikos, G. D.; Vishwanath, V. M. Friedel-Crafts acylation with N-(trifluoroacetyl)-.alpha.- amino acid chlorides. Application to the preparation of.beta.-arylalkylamines and 3-substituted 1,2,3,4-tetrahydroisoquinolines J. Org. Chem. 1984, 49 (22) 4107-4111
28. Buckley, T. F.; Rapoport, H. alpha.-Amino acids as chiral educts for asymmetric products. Amino acylation with N-acylamino acids J. Am. Chem. Soc. 1981, 103 (20) 6157-6163
29. Raja, E. K.; DeSchepper, D. J.; Nilsson Lill, S. O.; Klumpp, D. A. Friedel-Crafts Acylation with Amides J. Org. Chem. 2012, 77 (13) 5788-5793
30. Raja, E. K.; Nilsson Lill, S. O.; Klumpp, D. A. Friedel-Crafts-type reactions with ureas and thioureas Chem. Commun. 2012, 48 (65) 8141-8143
31. McMahon, R. J., Avidin-Biotin Interactions: Methods and Applications; Humana Press: New York, 2008.
32. Hermanson, G. T. In Bioconjugate Techniques, 2 nd ed.; Academic Press: New York, 2008; Chapter 23 (Avidin-Biotin Systems), pp 900-923.
33. Aslam, M.; Dent, A., Bioconjugation: protein coupling techniques for the biomedical sciences; Macmillan Reference: 1998.
34. Wilchek, M.; Bayer, E. A.; Livnah, O. Essentials of biorecognition: The (strept)avidin-biotin system as a model for protein-protein and protein-ligand interaction Immunol. Lett. 2006, 103 (1) 27-32
35. Stayton, P. S.; Freitag, S.; Klumb, L. A.; Chilkoti, A.; Chu, V.; Penzotti, J. E.; To, R.; Hyre, D.; Le Trong, I.; Lybrand, T. P.; Stenkamp, R. E. Streptavidin-biotin binding energetics Biomol. Eng. 1999, 16 (1-4) 39-44
36. Pordea, A.; Ward, T. R. Artificial Metalloenzymes: Combining the Best Features of Homogeneous and Enzymatic Catalysis Synlett 2009, 2009 (20) 3225-3236
37. Steinreiber, J.; Ward, T., Artificial Metalloenzymes for Enantioselective Catalysis Based on the Biotin-Avidin Technology. In Bio-inspired Catalysts; Ward, T., Ed.; Springer: Berlin, Heidelberg, 2009; Vol. 25, pp 93-112.
38. Thomas, C. M.; Ward, T. R. Design of artificial metalloenzymes Appl. Organomet. Chem. 2005, 19 (1) 35-39
39. Kasuya, T.; Jung, J.; Kinoshita, R.; Goh, Y.; Matsuzaki, T.; Iijima, M.; Yoshimoto, N.; Tanizawa, K.; Kuroda, S. i., Chapter 8-Bio-Nanocapsule-Liposome Conjugates for In Vivo Pinpoint Drug and Gene Delivery. In Methods in Enzymology; Nejat, D., Ed.; Academic Press: New York, 2009; Vol. 464, pp 147-166.
40. Dancey, G.; Begent, R.; Meyer, T. Imaging in targeted delivery of therapy to cancer Targ. Oncol. 2009, 4 (3) 201-217
41. Huang, S.-L. Liposomes in ultrasonic drug and gene delivery Adv. Drug Delivery Rev. 2008, 60 (10) 1167-1176
42. Niemeyer, C. M. Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science Angew. Chem., Int. Ed. 2001, 40 (22) 4128-4158
43. Katz, E.; Willner, I. Integrated Nanoparticle-Biomolecule Hybrid Systems: Synthesis, Properties, and Applications Angew. Chem., Int. Ed. 2004, 43 (45) 6042-6108
44. Ulrich, N. C.; Kuder, C. H.; Hohl, R. J.; Wiemer, D. F. Biologically active biotin derivatives of schweinfurthin F Bioorg. Med. Chem. Lett. 2010, 20 (22) 6716-6720
45. Kita, M.; Hirayama, Y.; Sugiyama, M.; Kigoshi, H. Development of Highly Cytotoxic and Actin-Depolymerizing Biotin Derivatives of Aplyronine A Angew. Chem., Int. Ed. 2011, 50 (42) 9871-9874
46. Zhong, B.; Lama, R.; Smith, K. M.; Xu, Y.; Su, B. Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76 Bioorg. Med. Chem. Lett. 2011, 21 (18) 5324-5327
47. Kang, Y.; Lou, C.; Ahmed, K. B. R.; Huang, P.; Jin, Z. Synthesis of biotinylated OSW-1 Bioorg. Med. Chem. Lett. 2009, 19 (17) 5166-5168
48. Pugliese, L.; Coda, A.; Malcovati, M.; Bolognesi, M. Three-dimensional Structure of the Tetragonal Crystal Form of Egg-white Avidin in its functional Complex with Biotin at 2·7 Å Resolution J. Mol. Biol. 1993, 231 (3) 698-710
49. Livnah, O.; Bayer, E. A.; Wilchek, M.; Sussman, J. L. Three-dimensional structures of avidin and the avidin-biotin complex Proc. Natl. Acad. Sci. U.S.A. 1993, 90 (11) 5076-5080
50. Chou, K.-C.; Carlacci, L.; Maggiora, G. G. Conformational and geometrical properties of idealized β-barrels in proteins J. Mol. Biol. 1990, 213 (2) 315-326
51. Pazy, Y.; Kulik, T.; Bayer, E. A.; Wilchek, M.; Livnah, O. Ligand Exchange between Proteins: Exchange of biotin and biotin derivatives between avidin and streptavidin J. Biol. Chem. 2002, 277 (34) 30892-30900
52. Salmon, A. J.; Williams, M. L.; Hofmann, A.; Poulsen, S.-A. Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors Chem. Commun. 2012, 48 (17) 2328-2330
53. Heine, A.; Stura, E. A.; Yli-Kauhaluoma, J. T.; Gao, C.; Deng, Q.; Beno, B. R.; Houk, K. N.; Janda, K. D.; Wilson, I. A. An Antibody exo Diels-Alderase Inhibitor Complex at 1.95 Angstrom Resolution Science 1998, 279 (5358) 1934-1940
54. Skander, M.; Humbert, N.; Collot, J.; Gradinaru, J.; Klein, G.; Loosli, A.; Sauser, J.; Zocchi, A.; Gilardoni, F.; Ward, T. R. Artificial Metalloenzymes: (Strept)avidin as Host for Enantioselective Hydrogenation by Achiral Biotinylated Rhodium-Diphosphine Complexes J. Am. Chem. Soc. 2004, 126 (44) 14411-14418
55. Kvarda, J.; Prokopová, I.; Kondelík, P. Reactivity of 6-Hexanelactam Cyclic Oligomers, 1. Acidolysis Macromol. Chem. Phys. 2001, 202 (1) 133-138
56. Yamazaki, Y.; Kohno, K.; Yasui, H.; Kiso, Y.; Akamatsu, M.; Nicholson, B.; Deyanat-Yazdi, G.; Neuteboom, S.; Potts, B.; Lloyd, G. K.; Hayashi, Y. Tubulin Photoaffinity Labeling with Biotin-Tagged Derivatives of Potent Diketopiperazine Antimicrotubule Agents ChemBioChem 2008, 9 (18) 3074-3081
57. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a Tetrazolium-based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing Cancer Res. 1987, 47 (4) 936-942
58. Giraldo, J.; Vivas, N. M.; Vila, E.; Badia, A. Assessing the (a)symmetry ofconcentration-effect curves: empirical versus mechanistic models Pharmacol. Ther. 2002, 95, 21-45
59. Otwinowski, Z.; Minor, W., [20] Processing of X-ray diffraction data collected in oscillation mode. In Methods in Enzymology; Carter, C. W., Jr., Ed. Academic Press: New York, 1997; Vol. 276, pp 307-326.
60. McCoy, A. J. Solving structures of protein complexes by molecular replacement with Phaser Acta Crystallographica Section D 2007, 63 (1) 32-41
61. McCoy, A. J.; Grosse-Kunstleve, R. W.; Adams, P. D.; Winn, M. D.; Storoni, L. C.; Read, R. J. Phaser crystallographic software J. Appl. Crystallogr. 2007, 40 (4) 658-674
62. Murshudov, G. N.; Vagin, A. A.; Dodson, E. J. Refinement of Macromolecular Structures by the Maximum-Likelihood Method Acta Crystallographica Section D 1997, 53 (3) 240-255
63. Emsley, P.; Cowtan, K. Coot: model-building tools for molecular graphics Acta Crystallogr., Sect. D 2004, 60 (12) 2126-2132
64. Lebedev, A. A.; Young, P.; Isupov, M. N.; Moroz, O. V.; Vagin, A. A.; Murshudov, G. N. JLigand: a graphical tool for the CCP4 template-restraint library Acta Crystallogr., Sect. D 2012, 68 (4) 431-440
65. Wallace, A. C.; Laskowski, R. A.; Thornton, J. M. LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions Protein Eng. 1995, 8 (2) 127-34